- Bio-tech Company GL Rapha has been chosen to produce 150 million doses of Russia's Sputnik V vaccine to battle against the COVID-19 in Korea every year, the Russian Direct Investment Fund (RDIF) said Friday.
- The statement was issued after the RDIF declared in August that Russia had commenced procedures to supply Korea with the world's "first" vaccine against the coronavirus in a number of months.
Tags : Sputnik V, coronavirus vaccine, COVID-19, epidemic, Biotech company, Rapha, Phase III trials, RDIF, 1.2 billion doses,
comments (0)